Related Experiment Video
Updated: Jun 25, 2026

10:36
A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
Rethinking Neonatal Surgical Urgency: Effective Delay with Internal Flow Restrictors
Lindsey M Reynolds1, Seth E M Wolf2, Rebekah R Boyd3
1Duke University School of Medicine, Durham, NC, USA; Duke Congenital Heart Surgery Research and Training Laboratory, Durham, NC, USA.
The Annals of Thoracic Surgery
|June 23, 2026
Summary
Percutaneous pulmonary flow restrictors effectively manage pulmonary overcirculation in high-risk neonates, bridging them to surgical decisions. This adjustable strategy improves physiologic stability and supports weight gain before definitive treatment.
Area of Science:
- Pediatric Cardiology
- Interventional Cardiology
- Neonatology
Background:
- Neonates with complex congenital heart disease often experience pulmonary overcirculation.
- Early surgical intervention can be risky due to instability, prematurity, or comorbidities.
Purpose of the Study:
- To evaluate the efficacy of percutaneous pulmonary flow restrictors as a bridge-to-decision strategy in high-risk neonates.
- To assess the impact on hemodynamic parameters, physiologic stabilization, and subsequent management.
Main Methods:
- Retrospective review of 38 neonates and infants undergoing percutaneous pulmonary flow restrictor placement.
- Assessment of hemodynamic (pulmonary-to-systemic flow ratio) and laboratory (lactate, creatinine) parameters pre- and post-placement.
- Evaluation of outcomes including stabilization, weight gain, interventions, and complications.
Main Results:
- Flow restrictor placement significantly reduced pulmonary blood flow (median P/S ratio from 3.6 to 0.84).
- Rapid improvements in lactate and creatinine were observed.
- 82% proceeded to surgery, with a median weight gain of 370g; 13% required repeat intervention.
Conclusions:
- Percutaneous pulmonary flow restrictors are a feasible and adaptable strategy for temporizing pulmonary overcirculation in high-risk neonates.
- This approach supports physiologic optimization and allows for individualized flow modulation.
- It facilitates assessment of clinical trajectory and candidacy for definitive intervention.